Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS).
Grivas P, Loriot Y, Morales-Barrera R, Teo MY, Zakharia Y, Feyerabend S, Vogelzang NJ, Grande E, Adra N, Alva A, Necchi A, Rodriguez-Vida A, Gupta S, Josephs DH, Srinivas S, Wride K, Thomas D, Simmons A, Loehr A, Dusek RL, Nepert D, Chowdhury S. Grivas P, et al. Among authors: josephs dh. BMC Cancer. 2021 May 24;21(1):593. doi: 10.1186/s12885-021-08085-z. BMC Cancer. 2021. PMID: 34030643 Free PMC article. Clinical Trial.
Cohort profile: King's Health Partners bladder cancer biobank.
Kotecha P, Moss CL, Enting D, Gillett C, Joseph M, Josephs D, Rudman S, Hughes S, Cahill F, Wylie H, Haire A, Rosekilly J, Khan MS, Nair R, Thurairaja R, Malde S, Van Hemelrijck M. Kotecha P, et al. BMC Cancer. 2020 Sep 25;20(1):920. doi: 10.1186/s12885-020-07437-5. BMC Cancer. 2020. PMID: 32977748 Free PMC article.
Graham Roberts Study protocol: first 'trials within cohort study' for bladder cancer.
Wylie H, Cahill F, Santaolalla A, Moss CL, Enting D, Amery S, Chatterton K, Khan MS, Bryan RT, Gillett C, Josephs D, Chowdhury S, Rudman S, Hughes S, Relton C, Van Hemelrijck M. Wylie H, et al. BMJ Open. 2019 Sep 26;9(9):e029468. doi: 10.1136/bmjopen-2019-029468. BMJ Open. 2019. PMID: 31558452 Free PMC article.
Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19.
So ACP, Karampera C, Khan M, Russell B, Moss C, Monroy-Iglesias MJ, Thillai K, Josephs DH, Pintus E, Rudman S, Van Hemelrijck M, Dolly S, Enting D. So ACP, et al. Among authors: josephs dh. BMC Urol. 2022 Apr 29;22(1):71. doi: 10.1186/s12894-022-01023-6. BMC Urol. 2022. PMID: 35488333 Free PMC article.
Radical cancer treatment is safe during COVID-19: the real-world experience of a large London-based Comprehensive Cancer Centre during the first wave.
Russell B, Moss C, Monroy-Iglesias M, Roberts G, Dickinson H, Haire K, Innes K, Mulji-Shah B, Castell F, Al-Salihi O, Lei M, Francis A, Dann B, Jogia V, Hamid H, Challacombe B, Simo R, Fraser S, Gousis C, Sawyer E, Tsotra E, Roca J, Khan M, Josephs D, Enting D, Van Hemelrijck M, Harris V, Dolly S. Russell B, et al. Br J Cancer. 2022 Oct;127(7):1289-1295. doi: 10.1038/s41416-022-01909-0. Epub 2022 Jul 15. Br J Cancer. 2022. PMID: 35840733 Free PMC article.
First-in-human study of CH5132799, an oral class I PI3K inhibitor, studying toxicity, pharmacokinetics, and pharmacodynamics, in patients with metastatic cancer.
Blagden S, Omlin A, Josephs D, Stavraka C, Zivi A, Pinato DJ, Anthoney A, Decordova S, Swales K, Riisnaes R, Pope L, Noguchi K, Shiokawa R, Inatani M, Prince J, Jones K, Twelves C, Spicer J, Banerji U. Blagden S, et al. Clin Cancer Res. 2014 Dec 1;20(23):5908-17. doi: 10.1158/1078-0432.CCR-14-1315. Epub 2014 Sep 17. Clin Cancer Res. 2014. PMID: 25231405 Free PMC article. Clinical Trial.
93 results